Sign in

CIK 0001979414

  • Emerging growth company

NEONC TECHNOLOGIES HOLDINGS, INC.

Sign in to watch
Ticker
NTHI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
921954864
Phone
+1 310-663-7831
Business address
23975 PARK SORRENTO, SUITE 205, CALABASAS, CA, 91302
  1. 4 Open-market buy Chief Clinical Officer bought 500 shares at $4.88 ($2,440)
  2. 4 Open-market buy CFO bought 300 shares at $5.38 ($1,614)
  3. 4 Open-market buy President bought 10,000 shares at $4.90 ($49,000)
  4. 4 Open-market buy Chief Accounting Officer bought 200 shares at $5.00 ($1,000)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy President bought 10,000 shares at $4.90 ($48,950)
  7. 4 Open-market buy President bought 15,000 shares at an average $5.47 ($82,000)
  8. 4 Open-market buy President bought 25,000 shares at an average $6.14 ($153,398)
  9. 4 Open-market buy President bought 30,000 shares at an average $6.16 ($184,660)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Chief Clinical Officer bought 1,100 shares at $6.69 ($7,359)
  12. 3/A Insider 3/A
  13. 4 Grant or award President acquired 1,200,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Chief Clinical Officer acquired 133,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4/A Open-market sale Director sold 57,696 shares at an average $24.85 ($1,433,912)
  18. 4/A Open-market sale COO sold 11,847 shares at an average $24.85 ($294,432)
  19. 4/A Open-market sale CFO sold 6,616 shares at an average $24.85 ($164,426)
  20. 4/A Open-market sale Director sold 38,464 shares at an average $24.85 ($955,941)

Page 2 of 4 · 71 filings